DEVELOPMENT OF NOVEL PRECLINICAL MODELS OF SECONDARY RESISTANCE TO THE PI3KΔ INHIBITOR IDELALISIB IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL)
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2438_119
Abstract: rubicin, epirubicin, vinblastine, etoposide, paclitaxel, and topotecan. RTI‐79's PK characteristics are similar to rifabutin and exhibited no overt toxicity in mice at high doses. RTI‐79 did not exacerbate the known cardiotoxicity associated with doxorubicin as… read more here.
Keywords: rti; novel preclinical; secondary resistance; preclinical models ... See more keywords
Experience of an academic institute in importing a novel preclinical drug into India
Sign Up to like & getrecommendations! Published in 2017 at "Indian Journal of Pharmacology"
DOI: 10.4103/ijp.ijp_292_17
Abstract: The article throws light on the process of importing a novel preclinical drug into India based on the real-life experience from one of our studies. A novel drug “X” acting through a new mechanism of… read more here.
Keywords: novel preclinical; preclinical drug; drug india; drug ... See more keywords